Article
KIAA1429 regulates the expression of RAB27B in a m6A YTHDF1 axis-dependent manner and promotes the progression of chronic myeloid leukemia, serving as a potential therapeutic target
2022-09-22
Abstract excerpt
<h4>Background: </h4> Chronic myeloid leukemia (CML) is one of the most common adult leukemias. The considerable negative changes in its acute phase and the adverse drug effects could lead to poor prognosis. N6-methyladenine (m6A) modification plays an important regulatory role in physiological and pathological processes. KIAA1429 is an important m6A regulator, but the biological role of KIAA1429 in CML is still u...
Topics
Open a Topic to create a Post that cites this publication.
- Cancer-related molecular mechanisms research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Chronic Myeloid Leukemia Treatments
- Down syndrome and intellectual disability research
- Quinazolinone synthesis and applications
- RNA Interference and Gene Delivery
- RNA modifications and cancer
- Viral-associated cancers and disorders
Identifiers and source
- Literature Corpus work
- 6d64e3a2-e54a-50a0-b452-b5639d510373
- DOI
- 10.21203/rs.3.rs-2072636/v1
